Top Markets
#1 CoW Protocol CoW Protocol +65.62%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +35.94%
#4 Cysic Cysic +24.17%
#5 Nockchain Nockchain +15.44%
#6 Velvet Velvet +15.00%
#7 Humanity Humanity +14.65%
#8 The Black Bull The Black Bull +13.24%
#9 Tutorial Tutorial +12.75%
#10 Versatize Coin Versatize Coin +12.49%
Coin of the day
CoW Protocol CoW Protocol
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Clasificación en acciones #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Precio por acción
$0.00060315
Última sincronización: 2024-09-27
Capitalización bursátil
$1.65M
Cambio (1 día)
19.64%
Cambio (1 año)
0.00%
País
SE
Comercio Amniotics AB (publ) (AMNI)

Categoría

Healthcare
Ratio P/S de Amniotics AB (publ) (AMNI)
Ratio P/S al August 2026 TTM: 0.00
Según los informes financieros más recientes y el precio de las acciones de Amniotics AB (publ), el ratio P/S actual (TTM) es 0.00. Al final de 2022, el ratio P/S era 0.00.
Historial del ratio P/S de Amniotics AB (publ) desde 2018 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE